A detailed history of Voya Investment Management LLC transactions in Bio Atla, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 14,805 shares of BCAB stock, worth $20,282. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,805
Previous 17,859 17.1%
Holding current value
$20,282
Previous $43,000 16.28%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$1.88 - $3.46 $5,741 - $10,566
-3,054 Reduced 17.1%
14,805 $50,000
Q2 2023

Aug 14, 2023

BUY
$2.83 - $3.87 $50,540 - $69,114
17,859 New
17,859 $53,000
Q3 2021

Nov 15, 2021

SELL
$29.44 - $43.74 $141,047 - $209,558
-4,791 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$32.41 - $70.91 $155,276 - $339,729
4,791 New
4,791 $244,000

Others Institutions Holding BCAB

About BioAtla, Inc.


  • Ticker BCAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,304,100
  • Market Cap $49.7M
  • Description
  • BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ...
More about BCAB
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.